John Forte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Amazon also boosting, well, going up, of course, and apple, man, youve seen them both over the last day and this morning perhaps no exception, later today, we get the apple phones, prime day has kicked off, carl it is a big day. And as it was for yesterday, in terms of the stocks. Indeed, were within 2 of all time highs on the s p, trying to get back to the september highs, jim but i wonder if you think the lead this morning are these loss provisions at jpmorgan. I am surprised positively i think what has happened is people arent spending, not borrowing, credit card losses, fine Small Business...

Pressures for boeing, downgrades at Credit Suisse and ubs renewed congressional scrutiny, shares tumbling 10 on the past week. Opioids on trial in ohio for Drug Companies reaching a last minute settlement ahead of a landmark First Federal opioid case. And Mark Zuckerberg speaking out, why the facebook ceo tells nbc news it is more important to be understood than it is to be liked. Shares of boeing under pressure, having its worst day in more than 2 1 2 years, losing almost 7 friday. As we said, Credit Suisse and ubs cut the stock to neutral from buy today boeing under scrutiny following the re...

And possibly easing sanctions on iran. Josh, kind of a quiet market day here interesting rotations going on what do you make of the action today . This week its just been incredible for anything of value versus growth, anything small over large and theres a tend densy when we see these outside moves. For example, russell up 5. 5 over the last week theres a tendency to look at that and say ive missed it or that has to be the top of something. When you actually go back and find examples of this sort of thing happening in the recent past, actually that always had taken place at notable bottoms in...

Her Covert Affairs team have no influence or insight into the resourcing over all. I cant comment that we can get back to you. Thank you for your comments, congressman. So thats exactly why we are here. I speak for a section of the pharmaceutical industry that few people actually appreciate, especially given the statistics that i referenced that two out of every three new drugs approved by the fda last year actually originated in companies that are small biopharmaceutical emerging companies. We dont have a voice in washington. Excelixis is not a member of pharma. Where a number of bio. We dont...

And selling today. There are those three stocks, tesla is down again as another firm gets negative on that name, now the worstperforming stock in the s p 500 losing another 5 today and barely hanging onto 160 as you saw, tough day for small caps as the rate is up, the russell is lower, it does take us to our talk, the return of volatility and if investors need to prepare for a pickup, especially with another federal meeting looming, lets ask joe terranova. Hes a cnbc contributor, is that your expectation . Is that what we are trending, its about to get interesting for little bit . I think the ...